Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (861-870 of 933) with videos related to

Pageof 94
Sort By:
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading schemeRiuko Ohashi, Guido Martignoni, Arndt Hartmann, et al.
Human Pathology|January 9, 2022
cMET: a prognostic marker in papillary renal cell carcinoma?Franziska Erlmeier, Benedict Bruecher, Christine Stöhr, et al.
Discover Oncology|September 22, 2022
Expression of nectin-4 in papillary renal cell carcinomaStefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, et al.
Journal of Clinical Pathology|September 29, 2021
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohortFriederike Kullmann, Pamela L Strissel, Reiner Strick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.
The American Journal of Surgical Pathology|July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary BladderMichelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trialsSonia L Villegas, Valentina Nekljudova, Nicole Pfarr, et al.
Journal of Crohn'S & Colitis|March 27, 2021
Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s DiseaseCorinna Lang-Schwarz, Miriam Angeloni, Abbas Agaimy, et al.
Science Immunology|August 8, 2017
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironmentGordon F Heidkamp, Jil Sander, Christian H K Lehmann, et al.
Breast Cancer Research and Treatment|September 26, 2014
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studiesJessica Salmen, Julia Neugebauer, Peter A Fasching, et al.
Pageof 94

Showing results (861-870 of 933) with videos related to

Sort By:
Pageof 94
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading schemeRiuko Ohashi, Guido Martignoni, Arndt Hartmann, et al.
Human Pathology|January 9, 2022
cMET: a prognostic marker in papillary renal cell carcinoma?Franziska Erlmeier, Benedict Bruecher, Christine Stöhr, et al.
Discover Oncology|September 22, 2022
Expression of nectin-4 in papillary renal cell carcinomaStefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, et al.
Journal of Clinical Pathology|September 29, 2021
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohortFriederike Kullmann, Pamela L Strissel, Reiner Strick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.
The American Journal of Surgical Pathology|July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary BladderMichelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trialsSonia L Villegas, Valentina Nekljudova, Nicole Pfarr, et al.
Journal of Crohn'S & Colitis|March 27, 2021
Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s DiseaseCorinna Lang-Schwarz, Miriam Angeloni, Abbas Agaimy, et al.
Science Immunology|August 8, 2017
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironmentGordon F Heidkamp, Jil Sander, Christian H K Lehmann, et al.
Breast Cancer Research and Treatment|September 26, 2014
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studiesJessica Salmen, Julia Neugebauer, Peter A Fasching, et al.
Pageof 94